These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35797656)
21. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry. La Manna A; Chisari A; Giacchi G; Capodanno D; Longo G; Di Silvestro M; Capranzano P; Tamburino C Catheter Cardiovasc Interv; 2016 Nov; 88(6):E155-E163. PubMed ID: 26756959 [TBL] [Abstract][Full Text] [Related]
22. Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography. Seo J; Kim Y; Kim BK; Hong SJ; Ahn CM; Kim JS; Cho DK; Ko YG; Choi D; Hong MK; Jang Y Cardiol J; 2020; 27(2):208-209. PubMed ID: 32463107 [No Abstract] [Full Text] [Related]
23. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound. Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845 [TBL] [Abstract][Full Text] [Related]
24. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100. Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164 [TBL] [Abstract][Full Text] [Related]
25. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries. Lane JP; Perkins LE; Sheehy AJ; Pacheco EJ; Frie MP; Lambert BJ; Rapoza RJ; Virmani R JACC Cardiovasc Interv; 2014 Jun; 7(6):688-95. PubMed ID: 24835327 [TBL] [Abstract][Full Text] [Related]
26. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline. Piraino D; Buccheri D; Andolina G Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582 [No Abstract] [Full Text] [Related]
28. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study. Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119 [TBL] [Abstract][Full Text] [Related]
29. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies. Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287 [TBL] [Abstract][Full Text] [Related]
30. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging. Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931 [No Abstract] [Full Text] [Related]
31. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. Onuma Y; Honda Y; Asano T; Shiomi H; Kozuma K; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Hanaoka KI; Tanabe K; Okada K; Kitahara H; Ono M; Kusano H; Rapoza R; Simonton C; Popma JJ; Stone GW; Fitzgerald PJ; Serruys PW; Kimura T JACC Cardiovasc Interv; 2020 Jan; 13(1):116-127. PubMed ID: 31918929 [TBL] [Abstract][Full Text] [Related]
32. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Bennett J; Adriaenssens T; Desmet W; Dubois C Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586 [TBL] [Abstract][Full Text] [Related]
33. Incidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions. Tanaka A; Jabbour RJ; Kawamoto H; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A Int J Cardiol; 2016 Nov; 222():674-675. PubMed ID: 27526354 [No Abstract] [Full Text] [Related]
34. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem. Foin N; Lee R; Wong P; Low AF EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237 [No Abstract] [Full Text] [Related]
35. One Year of OCT Follow-Up After Implantation of Three Different BRS in the Same Coronary Artery. Franzè A; Cerrato E; Rolfo C; Quadri G; Tomassini F; Varbella F Cardiovasc Revasc Med; 2020 Nov; 21(11S):121-122. PubMed ID: 32513605 [No Abstract] [Full Text] [Related]
36. Bioresorbable vascular scaffolds in left main coronary artery disease. Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148 [TBL] [Abstract][Full Text] [Related]